CTRI/2020/04/024423
Recruiting
N/A
Identification of Biomarkers for Central Nervous System Tuberculosis - CNSTB STUDY
niversity Hospital Frankfurt0 sites0 target enrollmentTBD
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Health Condition 1: A179- Tuberculosis of nervous system, unspecified
- Sponsor
- niversity Hospital Frankfurt
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Clinically suspected Central Nervous System Tuberculosis
Exclusion Criteria
- •Informed consent not given
- •Lumbar puncture not possible/not performed before start of treatment
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
Identification of a CSF- and blood biomarker fingerprint differentiating between highly active and moderate/mild forms of multiple sclerosis (MS)G35Multiple sclerosisDRKS00015761Klinikum der Johann Wolfgang Goethe-UniversitätZentrum der Neurologie und Neurochirurgie200
Not Yet Recruiting
N/A
Multiple neurophysiologic biomarkers evaluated the pulmonary function of ALS.amyotrophic lateral sclerosis(ALS)JPRN-UMIN000042222ara Medical University20
Completed
N/A
The value of biomarkers in cerebrospinal fluid in acute spinal cord injury as predictor of outcome.spinal cord injurytraumatic myelopathy10041543NL-OMON34689niversitair Medisch Centrum Sint Radboud30
Not Yet Recruiting
N/A
Assessment of clinical neurophysiological biomarkers for the differentiation of neurodegenerative disease versus non-neurological disorder in patients with mild cognitive impairment.cognitive disordersintellectual disabilitymild cognitive impairmentNL-OMON56487Centre for Human Drug Research30
Completed
N/A
BIOmarkers for cogNitive Impairment due to Cerebral Amyloid Angiopathy (BIONIC)NL-OMON44332Radboud Universitair Medisch Centrum375